Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Cui, W., and Kaech, S.M. (2010). Generation of effector CD8+ T cells and their conversion to
memory T cells. Immunol Rev 236, 151-166.
Curtsinger, J.M., Lins, D.C., and Mescher, M.F. (2003). Signal 3 determines tolerance versus
full activation of naive CD8 T cells: dissociating proliferation and development of effector
function. J Exp Med 197, 1141-1151.
Curtsinger, J.M., and Mescher, M.F. (2010). Inflammatory cytokines as a third signal for T
cell activation. Curr Opin Immunol 22, 333-340.
Curtsinger, J.M., Schmidt, C.S., Mondino, A., Lins, D.C., Kedl, R.M., Jenkins, M.K., and
Mescher, M.F. (1999). Inflammatory cytokines provide a third signal for activation of naive
CD4+ and CD8+ T cells. J Immunol 162, 3256-3262.
Curtsinger, J.M., Valenzuela, J.O., Agarwal, P., Lins, D., and Mescher, M.F. (2005). Type I
IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J
Immunol 174, 4465-4469.
D'Souza, W.N., and Hedrick, S.M. (2006). Cutting edge: latecomer CD8 T cells are imprinted
with a unique differentiation program. J Immunol 177, 777-781.
Daffis, S., Suthar, M.S., Szretter, K.J., Gale, M., Jr., and Diamond, M.S. (2009). Induction of
IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1dependent
signal that does not require IRF-3 and IRF-7. PLoS Pathog 5, e1000607.
Darrah, P.A., Patel, D.T., De Luca, P.M., Lindsay, R.W., Davey, D.F., Flynn, B.J., Hoff, S.T.,
Andersen, P., Reed, S.G., Morris, S.L., et al. (2007). Multifunctional TH1 cells define a
correlate of vaccine-mediated protection against Leishmania major. Nat Med 13, 843-850.
Decker, T., Muller, M., and Stockinger, S. (2005). The yin and yang of type I interferon
activity in bacterial infection. Nat Rev Immunol 5, 675-687.
del Rio, M.L., Rodriguez-Barbosa, J.I., Kremmer, E., and Forster, R. (2007). CD103- and
CD103+ bronchial lymph node dendritic cells are specialized in presenting and crosspresenting
innocuous antigen to CD4+ and CD8+ T cells. J Immunol 178, 6861-6866.
Delamarre, L., Pack, M., Chang, H., Mellman, I., and Trombetta, E.S. (2005). Differential
lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307, 1630-
1634.
den Haan, J.M., Lehar, S.M., and Bevan, M.J. (2000). CD8(+) but not CD8(-) dendritic cells
cross-prime cytotoxic T cells in vivo. J Exp Med 192, 1685-1696.
Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., and Reis e Sousa, C. (2004). Innate antiviral
responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303,
1529-1531.
Diken, M., Kreiter, S., Selmi, A., Britten, C.M., Huber, C., Tureci, O., and Sahin, U. (2011).
Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and
abrogated upon DC maturation. Gene Ther 18, 702-708.
Dillon, S.R., Jameson, S.C., and Fink, P.J. (1994). V beta 5+ T cell receptors skew toward
OVA+H-2Kb recognition. J Immunol 152, 1790-1801.
Dougan, M., Dougan, S., Slisz, J., Firestone, B., Vanneman, M., Draganov, D., Goyal, G., Li,
W., Neuberg, D., Blumberg, R., et al. (2010). IAP inhibitors enhance co-stimulation to
promote tumor immunity. J Exp Med 207, 2195-2206.
Drutman, S.B., and Trombetta, E.S. (2010). Dendritic cells continue to capture and present
antigens after maturation in vivo. J Immunol 185, 2140-2146.
Page 241 of 256